Effects of Shehuang Paste on hemodynamics, endotoxin, nitric oxide and endothelin-1 in patients with refractory cirrhotic ascites

Chinese Journal of Integrative Medicine

Volumn 12, Issue 4, 2006, Pages 255-261

  Tong, Guang Dong ^a   Zhou, Da Qiao ^a   He, Jin Song ^a   Li, Song Lin ^a   Peng, Li Sheng ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Hemodynamics; Liver cirrhosis; Refractory ascites; Vasoactive substance

Indexed keywords

CEFTAZIDIME; CHINESE DRUG; ENDOTHELIN 1; ENDOTOXIN; FUROSEMIDE; LIVER PROTECTIVE AGENT; MEGLUMINE; NITRIC OXIDE; PLACEBO; POTASSIUM; SHEHUANG; SILIBININ; SODIUM; UNCLASSIFIED DRUG; WUZHI;

ADULT; ARTICLE; ASCITES; COLOR ULTRASOUND FLOWMETRY; COLORIMETRY; CONTROLLED STUDY; DRUG EFFECT; DRUG SYNTHESIS; FEMALE; FOLLOW UP; HEMODYNAMICS; HUMAN; HUMAN TISSUE; LIMULUS LYSATE TEST; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PASTE; PORTAL VEIN BLOOD FLOW; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS; RADIOIMMUNOASSAY; SKIN REDNESS; SKIN SWELLING; SODIUM BLOOD LEVEL; SPLENIC VEIN; TREATMENT DURATION;

ADULT; ENDOTHELIN-1; ENDOTOXINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; NITRIC OXIDE; PORTAL VEIN; POTASSIUM; REGIONAL BLOOD FLOW; SODIUM;

EID: 33846144730     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11655-006-0255-4     Document Type: Article

References (16)

1. Liang KH, Li SB. Portal hypertension. Beijing: People's Military Medical Press, 1999: 192.
2. Moreau R. Hepatorenal syndrome in patients with cirrhosis. J Gastroenterol Hepatol 2002; 17(7): 739-774.
3. Wang JY. Modern treatment of hepatology. Shanghai: Shanghai Medical University Publishing House, 1999: 244.
4. Lv XP, Zhan LL, Jiang HH. Effect of changes of nitric oxide, endothelin and antidiuretic hormone on portal hypertension induced by hepatic cirrhosis. Clin Focus 2000; 15 (11): 384-386.
5. Chen MZ, Jiang ZM. Water and electrolyte balance in clinic. 2nd ed. Beijing: People's Medical Publishing House, 2000: 156.
6. Zhang XL, Ye XC. Research on navel sticking and recent developments. Chin J Med 1997; 32(12): 38-40.
7. Hu DS, Qian J, Jia H. Observation of efficacy of Xiaopeng Powder navel sticking in treating cirrhotic ascites. Tianjin J TCM 2001; 17(4): 201-203.
8. Zhang SB, Wen PK. Study on extraction of Moschus from Shehuang-Babuji. China Pharmacy 2005; 16(14): 1117-1118.
9. Liu LL, Zhang W. Clinical significance of portal haemodynamics using pulsed-wave Doppler. Med J Communication 1996; 10(2): 18-20.
10. Special Committee of Internal Heptatology, China Association of Chinese Medicine. Standards for efficacy evaluation of TCM on liver cirrhosis ascites (Draft). 1993: 101-103.
11. Vyas K, Gala B, Sawant P, et al. Assessment of portal hemodynamics by ultrasound colorized Doppler and laser Doppler velocimetry in liver cirrhosis. Indian J Gastroenterol 2002; 21(5): 176-178.
12. Chu CJ, Lee FY, Wang SS, et al. Splanchnic endotoxin levels in cirrhotic rats induced by carbon tetrachloride. Zhonghua Yi Xue Za Zhi (Taipei) 2000; 63(3): 196-204.
13. Spahr L, Martin PY, Giostra E, et al. Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites. J Invest Med 2002; 50(2): 116-124.
14. Such J, Frances R, Perez-Mateo M. Nitric oxide in patients with cirrhosis and bacterial infections. Metab Brain Dis 2002; 7(4): 303-309.
15. Gan HS, Chen YQ, Wu Y. The changes and clinical significance of nitric oxide in patients with cirrhosis. West Chin Med J 2000; 15(4): 154.
16. Jiangsu New Medical College. A Chinese materia medica dictionary 1995: 2741, 648, 415, 2316.